Coherus Oncology, Inc. Convertible Notes Payable, Noncurrent
Coherus Oncology, Inc. (CHRS) had Convertible Notes Payable, Noncurrent of $81.36 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes and Loans, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2022-02-23
- 2021-12-31: Convertible Notes Payable, Noncurrent $81.36M.
- 2020-12-31: Convertible Notes Payable, Noncurrent $79.89M.
- 2020-09-30: Convertible Notes Payable, Noncurrent $79.54M.
- 2020-06-30: Convertible Notes Payable, Noncurrent $79.20M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2021-12-31 | $81.36M 10-K · filed 2022-02-23 |
| 2020-12-31 | $79.89M 10-K · filed 2022-02-23 |
| 2020-09-30 | $79.54M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $79.20M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $78.87M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $78.54M 10-K · filed 2021-02-25 |
| 2019-09-30 | $78.23M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $77.92M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $77.61M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $77.32M 10-K · filed 2020-02-27 |
| 2018-09-30 | $77.03M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $76.75M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $76.47M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $76.21M 10-K · filed 2019-02-28 |
| 2017-09-30 | $75.94M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $75.69M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $75.44M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $75.19M 10-K · filed 2018-03-08 |
| 2016-09-30 | $74.95M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $74.72M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $74.49M 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |